We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.44B
AUM Growth
+$1.09B
(+15%)
Cap. Flow
+$577M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
15.63%
Holding
838
New
218
Increased
181
Reduced
162
Closed
220
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$123M |
| 2 |
HES
Hess
HES
|
+$115M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$108M |
| 4 |
Cencora
COR
|
+$106M |
| 5 |
Microsoft
MSFT
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$108M |
| 2 |
Analog Devices
ADI
|
+$105M |
| 3 |
Keysight
KEYS
|
+$101M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$82.2M |
| 5 |
Booking.com
BKNG
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.55% |
| 2 | Technology | 28% |
| 3 | Industrials | 9.43% |
| 4 | Energy | 7.74% |
| 5 | Consumer Discretionary | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Ulta Beauty
ULTA
$23B
| $7.1M | 0.08% |
15,080
-10,348
| -41% | -$5.07M |
|
252
BellRing Brands
BRBR
$1.51B
| $7.08M | 0.08% |
193,316
-19,725
| -9% | -$707K |
|
253
Structure Therapeutics
GPCR
$3.44B
| $7.07M | 0.08% |
170,000
| – | – |
|
254
Zscaler
ZS
$25B
| $7.01M | 0.08% |
47,882
-246,067
| -84% | -$30M |
|
255
Tyra Biosciences
TYRA
$1.91B
| $6.99M | 0.08% |
410,435
| – | – |
|
256
Biohaven
BHVN
$2.01B
| $6.97M | 0.08% |
291,581
+89,285
| +44% | +$1.54M |
|
257
Xponential Fitness
XPOF
$278M
| $6.71M | 0.08% |
388,701
-36,299
| -9% | -$1.03M |
|
258
Yum China
YUMC
$16.6B
| $6.53M | 0.08% |
115,600
+109,960
| +1,950% | +$6.63M |
|
|
BRSL
259
Brightstar Lottery PLC
BRSL
$1.86B
| $6.51M | 0.08% |
204,233
-300,976
| -60% | -$8.36M |
|
|
SEE
260
DELISTED
Sealed Air
SEE
| $6.39M | 0.08% |
159,817
-136,435
| -46% | -$5.8M |
|
261
Replimune Group
REPL
$1B
| $6.39M | 0.08% |
275,001
-36,849
| -12% | -$720K |
|
262
DigitalOcean
DOCN
$14.9B
| $6.27M | 0.07% |
+156,169
| New | +$5.76M |
|
263
Zai Lab
ZLAB
$2.05B
| $6.18M | 0.07% |
223,032
-113,934
| -34% | -$3.73M |
|
|
STKL
264
DELISTED
SunOpta
STKL
| $6.16M | 0.07% |
921,493
-1,046,671
| -53% | -$7.88M |
|
265
Woodward
WWD
$21.5B
| $5.99M | 0.07% |
+50,397
| New | +$5.34M |
|
266
Warner Music
WMG
$13.1B
| $5.92M | 0.07% |
226,974
-4,604
| -2% | -$128K |
|
267
Advance Auto Parts
AAP
$3.36B
| $5.91M | 0.07% |
84,053
-1,300
| -2% | -$134K |
|
|
KLRS
268
Kalaris Therapeutics
KLRS
$96.4M
| $5.88M | 0.07% |
75,131
+31,653
| +73% | +$3.01M |
|
269
McKesson
MCK
$96.8B
| $5.85M | 0.07% |
13,689
-11,508
| -46% | -$4.42M |
|
270
IQVIA
IQV
$38.4B
| $5.8M | 0.07% |
+25,806
| New | +$5.18M |
|
271
BlackRock MuniHoldings Fund
MHD
$601M
| $5.76M | 0.07% |
495,024
-190,716
| -28% | -$2.22M |
|
272
Leggett & Platt
LEG
$1.37B
| $5.71M | 0.07% |
192,726
-171,445
| -47% | -$5.39M |
|
273
Arbutus Biopharma
ABUS
$861M
| $5.68M | 0.07% |
2,469,197
-188,408
| -7% | -$490K |
|
|
ISEE
274
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.54M | 0.07% |
140,700
-148,758
| -51% | -$5.25M |
|
|
ISEE
275
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.54M | 0.07% |
+140,700
| New | +$4.97M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Woodline Partners held 838 positions worth $8.44B, up 15% from $7.35B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $577M of net new capital in Q2 2023, opening 218 new positions and adding to 181 existing holdings. Its largest new stake was Hess: 837,083 shares worth $114M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $101M trimmed.
- Woodline Partners's largest Q2 2023 buy was Hess: 837,083 shares worth $114M.
- Woodline Partners added most to Johnson & Johnson in Q2 2023, an estimated $123M increase.
- Woodline Partners's biggest Q2 2023 reduction was Keysight, cutting an estimated $101M.
- Woodline Partners fully exited Baxter International in Q2 2023, selling an estimated $108M.
- Woodline Partners's ten largest holdings make up 16% of its $8.44B portfolio in Q2 2023.
- Woodline Partners opened 218 new positions and closed 220 in Q2 2023.
- Woodline Partners's portfolio value rose 15% quarter-over-quarter to $8.44B.
Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.